FDA Lymerix Adverse Event Study Set For 2002; Survey To Be Finished By Dec.

FDA's Center for Biologics Evaluation & Research plans to begin a case control study of GlaxoSmithKline's Lymerix in 2002, following the completion of its survey of Lymerix vaccinees.